Business Context and Reporting Period
This Form 8-K Current Report was filed by V2X, Inc. on August 10, 2026, covering events occurring on August 6 and August 7, 2026. The company is incorporated in Indiana and trades on the New York Stock Exchange under the symbol VVX.
Key Financial Metrics
This filing does not contain comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only specific financial figure disclosed is a one-time separation payment of $331,975 to a departing executive.
Material Changes
- Executive Departure: Dr. L. Roger Mason, Jr. resigned effective August 7, 2026, from his roles as Senior Vice President and Chief Growth Officer.
- Reason for Departure: Dr. Mason is leaving to serve as the Director of the National Reconnaissance Office of the U.S. Department of War.
- Succession: CEO Jeremy C. Wensinger will assume Dr. Mason's responsibilities until a successor is appointed.
- Disagreement Status: The filing explicitly states the resignation is not due to any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Management Commentary
The filing does not provide updated financial guidance, outlook, or general management commentary on business performance. The primary commentary focuses on the transition of duties and the terms of the separation agreement, which includes a release of all claims by the departing executive.
Investor Verification Checklist
- Verify the impact of the Chief Growth Officer vacancy on the company's strategic growth initiatives.
- Confirm the timeline for the appointment of a permanent successor to Dr. Mason.
- Review the full text of the Release Agreement (Exhibit 10.1) for any additional non-disclosure or non-compete terms.
- Monitor future filings for any changes in executive compensation structure resulting from this departure.